Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 17.291\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: COC(CNC(=O)c1cn(C)c2ccc(S(=O)(=O)N3CCOCC3)cc2c1=O)OC
b: COc1cc2c(cc1OC)C(C(=O)N(C)Cc1ccccc1)C(c1cccnc1)N(C)C2=O
c: COC(=O)/C=C1\S/C(=N\N=C\CC(=O)OC)NC1=O
Answer: c. COC(=O)/C=C1\S/C(=N\N=C\CC(=O)OC)NC1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)/C=C1\S/C(=N\N=C\CC(=O)OC)NC1=O
COC(=O)/C=C1\S/C(=N\N=C\CC(=O)OC)NC1=O
methyl (3E)-3-[(Z)-[(5Z)-5-(2-methoxy-2-oxoethylidene)-4-oxo-1,3-thiazolidin-2-ylidene]hydrazinylidene]propanoate